Literature DB >> 20097539

Acute and long-term nutrient-led modifications of gene expression: potential role of SIRT1 as a central co-ordinator of short and longer-term programming of tissue function.

Mark J Holness1, Paul W Caton, Mary C Sugden.   

Abstract

Environmental factors can influence the acute and longer-term risks of developing diseases, including type 2 diabetes mellitus and cardiovascular disease; however, the underlying mechanism remains elusive. Increasing evidence suggests that these effects can be achieved by modification of metabolic gene expression. These include acute changes in histone methylation, acetylation, phosphorylation, and ubiquitination and longer-term DNA silencing elicited by DNA methylation. Thus, an increased risk of disease may reflect acute or chronic stable modification of genes that regulate nutrient handling, leading to altered nutrient utilization (increased lipid oxidation at the expense of glucose utilization) and/or changes in the balance between nutrient storage and energy production, thereby favoring the development of obesity. The review addresses the hypothesis that early-life epigenetic programming of gene expression could be mirrored by changes in acute function of nuclear receptors, in particular the peroxisome proliferator-activated receptors, achieved by enzymes that are more conventionally involved in regulating DNA methylation and post-transcriptional modification of histones. Emphasis is placed on the potential importance of the protein deacetylase sirtuin-1 as a central co-ordinator. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097539     DOI: 10.1016/j.nut.2009.09.012

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  8 in total

Review 1.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

2.  Linoleic and α-linolenic fatty acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism.

Authors:  Carolina B Jacometo; Eduardo Schmitt; Luiz F M Pfeifer; Augusto Schneider; Francielle Bado; Fernanda T da Rosa; Simone Halfen; Francisco A B Del Pino; Juan J Loor; Marcio N Corrêa; Nelson J L Dionello
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

Review 3.  Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Krzysztof Reiss
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

4.  Early life programming and metabolic syndrome.

Authors:  Xiu-Min Wang
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

5.  Green tea extract increases mRNA expression of enzymes which influence epigenetic marks in newborn female offspring from undernourished pregnant mother.

Authors:  Yongkun Sun; Yuuka Mukai; Masato Tanaka; Takeshi Saito; Shin Sato; Masaaki Kurasaki
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

6.  Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin.

Authors:  Zhi Zheng; Haibing Chen; Jun Li; Tao Li; Bingqing Zheng; Ying Zheng; Huiyi Jin; Ying He; Qing Gu; Xun Xu
Journal:  Diabetes       Date:  2011-11-28       Impact factor: 9.461

7.  Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N-3 polyunsaturated fatty acids.

Authors:  Wenwen Shen; Cui Wang; Lulu Xia; Chaonan Fan; Hua Dong; Richard J Deckelbaum; Kemin Qi
Journal:  Sci Rep       Date:  2014-06-13       Impact factor: 4.379

Review 8.  Epigenetic Programming and Fetal Metabolic Programming.

Authors:  Ziqiang Zhu; Fang Cao; Xiaozhong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-03       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.